Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | PAYP | GEN |
|---|---|---|
| Price | $15.51 | $22.80 |
| Change today | ▲ 1.64% | ▲ 2.33% |
| Market cap | $10.50B | $13.65B |
| Return, 3 months | +4.1% | -11.3% |
| Return, year to date | – | -14.9% |
| Return, 1 year | – | -14.8% |
| P/E (TTM) | 14.4 | 13.3 |
| P/B | 4.2 | 5.1 |
| P/E percentile vs own 5y | 34th | 20th |
| Dividend yield | – | 2.19% |
| Revenue growth (YoY, latest qtr) | +27.8% | +6.3% |
| Net profit growth (YoY) | +82.7% | +59.3% |
| Gross margin | 87.5% | 78.0% |
| Operating margin | 30.8% | 42.8% |
| Net margin | 31.5% | 20.7% |
| Return on equity | 40.4% | 41.9% |
| Analyst target vs. price | +42.9% | +36.0% |
| Analyst buy share | 83% | 43% |
| RSI (14) | 42 | 34 |
| 30-day volatility | 47.0% | 57.6% |
| Max drawdown, 1 year | -49.6% | -37.9% |
| Trend read | Strong downtrend | Strong downtrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
